Evidence map›Paper›PMID 23559463›Full record

ArticleThe Journal of infectious diseases2013

Perinatal exposure of patas monkeys to antiretroviral nucleoside reverse-transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age.

Ofelia A Olivero, Lorangelly Rivera Torres, Sayeh Gorjifard, Dariya Momot, Eryney Marrogi, Rao L Divi, Yongmin Liu, Ruth A Woodward, Marsha J Sowers, Miriam C Poirier

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ofelia A OliveroCarcinogen-DNA Interactions Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892-4255, USA.
Lorangelly Rivera Torres
Sayeh Gorjifard
Dariya Momot
Eryney Marrogi
Rao L Divi
Yongmin Liu
Ruth A Woodward
Marsha J Sowers
Miriam C Poirier
Center for Cancer Research · USCancer Genetics (United States) · USNational Institutes of Health · US

Funding

Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugsZIABC010770 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POIRIER, MIRIAM C · 2009 to 2018
$9.0M
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundErythrocebus patas (patas) monkeys were used to model antiretroviral (ARV) drug in human immunodeficiency virus type 1-infected pregnant women.

methodsPregnant patas dams were given human-equivalent doses of ARVs daily during 50% of gestation. Mesenchymal cells, cultured from bone marrow of patas offspring obtained at birth and at 1 and 3 years of age, were examined for genotoxicity, including centrosomal amplification, micronuclei, and micronuclei containing whole chromosomes.

resultsCompared with controls, statistically significant increases (P < .05) in centrosomal amplification, micronuclei, and micronuclei containing whole chromosomes were found in mesenchymal cells from most groups of offspring at the 3 time points.

conclusionsTransplacental nucleoside reverse-transcriptase inhibitor exposures induced fetal genotoxicity that was persistent for 3 years.

Indexed as

HIV-1Prenatal Exposure Delayed EffectsAnimalsAnimals, NewbornAnti-HIV AgentsErythrocebus patasFemaleHumansMesenchymal Stem CellsMesodermNucleosidesPregnancyPregnancy Complications, InfectiousReverse Transcriptase InhibitorsAnti-HIV AgentsNucleosidesReverse Transcriptase Inhibitorsabacaviraneuploidycentrosomal amplificationErythrocebus pataslamivudinemesenchymal fibroblastsmicronucleinevirapinezidovudine

Identifiers

PMID23559463
PMCPMC3685224
OpenAlexW2166459320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.